Ambien in Argentina: prescription, pharmacy and pricing
Ambien (Zolpidem) is available in Argentina under the regulatory framework of ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica). This page summarises how the medication is prescribed and dispensed locally, what insurance or the public system cover, and which options exist for legally and safely accessing Ambien 5mg, 10mg, 6.25mg CR, 12.5mg CR.
- Regulator
- ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)
- Currency
- ARS
- Active ingredients
- Zolpidem
- Available dosages
- 5mg, 10mg, 6.25mg CR, 12.5mg CR
Prescription status in Argentina
In Argentina, prescription-only medications are dispensed against signed and stamped prescriptions; certain controlled medications use special triplicate forms. Many medications are otherwise available with pharmacist-only oversight. Ambien contains the active ingredient Zolpidem, in the Sleep Aids and Hypnotics class, and its classification in Argentina follows the standard rules of ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica).
Pharmacy dispensing
Farmacias argentinas operate as independent businesses or small chains; the pharmacist is a respected first-line consultant. Coverage by social security funds (obra social) often subsidises chronic medications. The pharmacist is the most reliable local source of information on stock, authorised substitutions (generic vs brand) and specific precautions for Ambien at the available strengths (5mg, 10mg, 6.25mg CR, 12.5mg CR).
Online and tele-prescribing access
Online sale of prescription medication is regulated by ANMAT and largely limited to authorised pharmacy chains; informal online sources are common but not legal channels. Buying Ambien from unauthorised sellers or without local verification exposes the user to counterfeit medication and unmonitored use of Zolpidem.
When Ambien is prescribed
Ambien is approved in adults for the short-term treatment of insomnia, typically when difficulty falling asleep or maintaining sleep is associated with daytime impairment.
Pricing and availability in ARS
Retail pricing in Argentina depends on the strength (5mg, 10mg, 6.25mg CR, 12.5mg CR), whether the original brand or an authorised generic is dispensed, and insurance or public-system coverage. The difference between brand and generic is usually the most meaningful economic lever for ongoing use. Comparing prices at two or more locally authorised pharmacies before first refill is recommended.
Frequently asked questions
Do I need a prescription for Ambien in Argentina? ▾
In Argentina, prescription-only medications are dispensed against signed and stamped prescriptions; certain controlled medications use special triplicate forms. Many medications are otherwise available with pharmacist-only oversight. In practice, Ambien follows the status of its active ingredient Zolpidem in the regulatory system of ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica).
Is generic Ambien available in Argentina? ▾
Authorised generics of Zolpidem are typically available in Argentina at a lower cost than branded Ambien, with bioequivalence required by ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica). Substitution is handled by the pharmacist under local equivalence rules.
How much does Ambien cost in ARS? ▾
Prices in ARS vary by pharmacy and by strength (5mg, 10mg, 6.25mg CR, 12.5mg CR). Authorised generics of Zolpidem are usually substantially cheaper than the brand and are the typical economic reference point for ongoing use in Argentina.
Ambien in other countries
- the United StatesFDA (Food and Drug Administration)
- the United KingdomMHRA (Medicines and Healthcare products Regulatory Agency)
- SpainAEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
- MexicoCOFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios)
- GermanyBfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
- FranceANSM (Agence nationale de sécurité du médicament et des produits de santé)
- ItalyAIFA (Agenzia Italiana del Farmaco)
- BrazilANVISA (Agência Nacional de Vigilância Sanitária)
- CanadaHealth Canada
- South KoreaMFDS (Ministry of Food and Drug Safety)
- JapanPMDA (Pharmaceuticals and Medical Devices Agency)
- AustriaBASG (Federal Office for Safety in Health Care)
- SwitzerlandSwissmedic (Swiss Agency for Therapeutic Products)
- AustraliaTGA (Therapeutic Goods Administration)
- ColombiaInvima (National Food and Drug Surveillance Institute)
- ChileISP (Instituto de Salud Pública de Chile, Public Health Institute)
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.